ChemoCentryx   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Mountain View CA United States (1997)

Organization Overview

First Clinical Trial
2004
NCT00102921
First Marketed Drug
2021
avacopan
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

ChemoCentryx | CHEMOCENTRYX | ChemoCentryx Inc | ChemoCentryx, Inc | ChemoCentryx, Inc.